Literature DB >> 29393241

The Heterogeneity of Prostate Cancer: A Practical Approach.

Yuri Tolkach, Glen Kristiansen.   

Abstract

Prostate cancer is a paradigm tumor model for heterogeneity in almost every sense. Its clinical, spatial, and morphological heterogeneity divided by the high-level molecular genetic diversity outline the complexity of this disease in the clinical and research settings. In this review, we summarize the main aspects of prostate cancer heterogeneity at different levels, with special attention given to the spatial heterogeneity within the prostate, and to the standard morphological heterogeneity, with respect to tumor grading and modern classifications. We also cover the complex issue of molecular genetic heterogeneity, discussing it in the context of the current evidence of the genetic characterization of prostate carcinoma; the interpatient, intertumoral (multifocal disease), and intratumoral heterogeneity; tumor clonality; and metastatic disease. Clinical and research implications are summarized and serve to address the most pertinent problems stemming from the extreme heterogeneity of prostate cancer.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Clonality; Genetic; Grading; Heterogeneity; Molecular; Pathology; Prostate cancer

Mesh:

Year:  2018        PMID: 29393241     DOI: 10.1159/000477852

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  30 in total

1.  Cancer-stromal cell fusion as revealed by fluorescence protein tracking.

Authors:  Ruoxiang Wang; Michael S Lewis; Ji Lyu; Haiyen E Zhau; Stephen J Pandol; Leland W K Chung
Journal:  Prostate       Date:  2019-12-17       Impact factor: 4.104

2.  Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies.

Authors:  Daniel N Costa; Qi Cai; Yin Xi; Debora Z Recchimuzzi; Naveen Subramanian; Aditya Bagrodia; Neil M Rofsky; Claus G Roehrborn; Brad Hornberger; Rajal B Shah; Kenneth Goldberg; Alberto Diaz de Leon; Ivan Pedrosa
Journal:  Radiol Imaging Cancer       Date:  2021-03-05

3.  Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.

Authors:  Morgan L Zenner; Yves B Helou; Ryan J Deaton; Maria Sverdlov; Heng Wang; Andre Kajdacsy-Balla; Virgilia Macias; Cindy Voisine; Marcus Murray; Sarki A Abdulkadir; Adam B Murphy; Larisa Nonn
Journal:  Prostate       Date:  2021-12-02       Impact factor: 4.104

4.  Radiomic Machine Learning and External Validation Based on 3.0 T mpMRI for Prediction of Intraductal Carcinoma of Prostate With Different Proportion.

Authors:  Ling Yang; Zhengyan Li; Xu Liang; Jingxu Xu; Yusen Cai; Chencui Huang; Mengni Zhang; Jin Yao; Bin Song
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

Review 5.  Interaction between prostate cancer stem cells and bone microenvironment regulates prostate cancer bone metastasis and treatment resistance.

Authors:  Lu Yao; Xiangyu Zhang
Journal:  J Cancer       Date:  2022-06-13       Impact factor: 4.478

Review 6.  Cancer overdiagnosis: a biological challenge and clinical dilemma.

Authors:  Sudhir Srivastava; Eugene J Koay; Alexander D Borowsky; Angelo M De Marzo; Sharmistha Ghosh; Paul D Wagner; Barnett S Kramer
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

Review 7.  Lemur Tyrosine Kinases and Prostate Cancer: A Literature Review.

Authors:  Elena Ferrari; Valeria Naponelli; Saverio Bettuzzi
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

8.  Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.

Authors:  Mª Jesús Núñez-Iglesias; Silvia Novio; Carlota García; Mª Elena Pérez-Muñuzuri; María-Carmen Martínez; José-Luis Santiago; Susana Boso; Pilar Gago; Manuel Freire-Garabal
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

9.  A Pilot Study of Multidimensional Diffusion MRI for Assessment of Tissue Heterogeneity in Prostate Cancer.

Authors:  Björn J Langbein; Filip Szczepankiewicz; Carl-Fredrik Westin; Camden Bay; Stephan E Maier; Adam S Kibel; Clare M Tempany; Fiona M Fennessy
Journal:  Invest Radiol       Date:  2021-12-01       Impact factor: 6.016

10.  Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.

Authors:  Caroline N Barquilha; Nilton J Santos; Caio C D Monção; Isabela C Barbosa; Flávio O Lima; Luis A Justulin; Nelma Pértega-Gomes; Sérgio L Felisbino
Journal:  Oxid Med Cell Longev       Date:  2020-01-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.